Abstract Purpose of Review Arrhythmias are common in patients with heart failure (HF) and
are associated with a significant risk of mortality and morbidity. Optimal antiarrhythmic …

Background Growing evidence suggests that atrial fibrillation (AF) is an independent risk
factor for cognitive impairment and dementia, even in the absence of thromboembolic events …

Availability of devices capable of continuous rhythm monitoring such as smartwatches,
implantable loop recorders, or pacemakers/defibrillators is continuously increasing …

Atrial fibrillation (AF) is common in patients with chronic kidney disease (CKD) undergoing
hemodialysis and in this patient population, management in terms of oral anticoagulation …

Abstract Background and Aims Clinical concerns exist about the potential proarrhythmic
effects of the sodium channel blockers flecainide and propafenone (SCB) in patients with …

Aims Right heart disease (RHD), characterized by right ventricular (RV) and atrial (RA)
hypertrophy, and cardiomyocytes'(CM) dysfunctions have been described to be associated …

For a number of antiarrhythmics, drug loading requires a 3-day hospitalization with
continuous monitoring for QT-prolongation. Automated QT monitoring with wearable ECG …

Background The favorable benefits of early rhythm control (ERC) therapy in newly
diagnosed patients with atrial fibrillation (AF) have been demonstrated in the EAST-AFNET 4 …

Electrocardiographic findings and arrhythmias are common in cardiomyopathies. Both may
be an early indication of a specific diagnosis or may occur due to myocardial fibrosis and/or …

Objective and Background Data on incidence of in-hospital pulmonary embolisms (PE) after
catheter ablation (CA) are scarce. To gain further insights, we sought to provide new findings …